Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant: A Randomized Clinical Study
Keratinized Tissue Augmentation Using Porcine Collagen Matrix (Mucoderm®) Around Dental Implant: A Randomized Clinical Study
Aim of the Study To evaluate the using of porcine collagen matrix for keratinized tissue augmentation around delayed dental implant.
Primary Outcome:
Peri-implant keratinized mucosal width and thickness following the use of porcine collagen matrix using (Mucoderm®-Botiss gmbh) compared to the gold standard FGG augmentation.
Secondary Outcome:
P: Population:
Patient with suitable ridge dimension for delayed implant placement.
I: Intervention:
Implant insertion followed by porcine collagen matrix soft tissue augmentation
C: Control:
Autogenous FGG
O: Outcomes
Enhancing keratinized mucosal width and thickness
Evaluating :
this study aiming to augment KMW with FGG and MUCODERM following apically positioned flap the primary outcomes to measure is KMW and MT
Inclusion Criteria:
1- Partially or fully edentulous sites with previous implant placed in posterior maxillary or mandibular areas.
2- Inadequate keratinized tissue ≤2 3- Patient age ranged from 20 to 45 years old for both genders. 4- Submerged Osteointegrated implants with no sings of inflammation before implant insertion.
5- Optimal compliance as evidenced by no missed treatment appointments and positive attitude toward oral hygiene.
Exclusion Criteria: